Knowles (KN) Q2 2025: Bookings Climb 15% as MedTech and Precision Devices Fuel Growth Trajectory
Knowles delivered a third consecutive quarter of broad-based bookings growth, with MedTech and precision devices driving upside and order momentum extending into Q3. The company’s proximity manufacturing model kept tariff risk contained, while design wins and normalized distribution inventory signaled a period of accelerated organic growth. Management’s conviction in sustained margin expansion and strategic investments in specialty film and inductor lines position Knowles for an above-trend growth profile into 2026.
Summary
- Bookings Momentum Surges: Precision Devices segment posted a book-to-bill above 1.15, with broad-based order strength.
- MedTech Resilience Returns: Hearing health and specialty audio demand rebounded after a brief Q1 pause.
- Growth Investments Underway: Specialty film and inductor lines target higher organic growth through 2026.
Performance Analysis
Knowles’ Q2 results outpaced expectations, with revenue and cash generation exceeding guidance and both core segments contributing to year-over-year growth. The MedTech and Specialty Audio (MSA) segment rebounded from a Q1 lull, posting a 10% YoY gain as hearing health and specialty audio demand normalized. This segment now accounts for approximately 46% of total revenue, underscoring its centrality to Knowles’ business model—custom engineered acoustic and electronic components for essential medical and industrial devices.
The Precision Devices (PD) segment, comprising 54% of revenue, continued its run of positive bookings trends, with a third straight quarter of book-to-bill above 1.0 and Q2 bookings topping 1.15. Gross margin dynamics were mixed: company-wide margins improved sequentially but faced YoY compression in MSA due to unfavorable mix and higher factory costs, while PD margins expanded on higher utilization and improved pricing. Operating leverage was evident in cash from operations, which exceeded $36 million, supporting both share buybacks and future growth investments.
- Distribution Inventory Normalization: Channel demand returned as inventory levels stabilized, fueling order acceleration.
- Capacity Utilization Drives Margins: PD segment margin gains tied to higher factory throughput and pricing discipline.
- Cash Generation Supports Buybacks: $30 million in Q2 repurchases reflect robust operating cash flows and low net leverage.
Strategic capital allocation remains a lever, with management balancing organic investments, M&A, and buybacks, enabled by a net leverage ratio of just 0.7x and over $350 million in liquidity.
Executive Commentary
"With the acceleration of design wins and order activity, we are positioned well for organic growth in 2025. Beyond 2025, we expect an increase of organic growth rates from historical levels as new initiatives such as the expansion of our specialty film production line comes online. Additionally, new products, such as our inductor line, which we just announced last week, has the potential to expand our TAM and drive future growth."
Jeff, President and CEO
"Gross margins in the second quarter improved 200 basis points sequentially, and we expect gross margins to remain in the low 50% range in the second half of the year. We continue to expect to generate operating cash flow of 16 to 20% of revenues for full year 2025."
John, Chief Financial Officer
Strategic Positioning
1. Proximity Manufacturing and Tariff Mitigation
Knowles’ proximity manufacturing model—producing goods near end markets—limits tariff exposure to less than 5% of revenue and 3% of COGS. This operational design, coupled with localized sourcing, allows the company to pass through incremental costs without losing business, reducing macro risk compared to peers with more globalized supply chains.
2. Secular Growth in MedTech and Defense
Essential device status in MedTech (hearing aids, implantables, imaging) and stable defense program participation shield Knowles from economic volatility. Management emphasized that these end markets have historically seen only modest short-term impacts from recessions, with demand quickly rebounding, as evidenced by the Q2 hearing health recovery.
3. Precision Devices: Design Win Flywheel
Precision Devices is experiencing a sustained design win cycle, driving a robust pipeline and expanding addressable market (TAM, total addressable market). Normalized channel inventory and broad-based demand across medical, industrial, and defense end markets underpin a higher organic growth trajectory, trending toward the upper end of management’s 4–6% target range.
4. Specialty Film and Inductor Expansion
Capacity expansion in specialty film and the launch of a new inductor product line are strategic bets to unlock incremental growth. Specialty film revenue is expected to ramp in late 2025 and 2026, initially serving MedTech, defense, and industrial customers. The inductor line, leveraging ceramic capacitor expertise, targets revenue contribution within 24 months, broadening Knowles’ product portfolio.
5. Disciplined Capital Allocation and M&A Optionality
Strong cash generation and low leverage provide flexibility to pursue synergistic acquisitions, organic investments, and continued share buybacks. Management described the M&A pipeline as active, with a focus on consolidation, extensions, and adjacencies, while reiterating a disciplined approach to deal selection and capital deployment.
Key Considerations
This quarter marks a strategic inflection for Knowles, as broad-based order strength and normalized distribution channels set the stage for above-trend organic growth. The company’s operational model and capital discipline create resilience and optionality heading into a period of product and market expansion.
Key Considerations:
- Bookings Quality: Three consecutive quarters of book-to-bill above one in Precision Devices, with Q2 at 1.15, signal durable demand.
- MedTech as a Defensive Anchor: Essential device status and rapid demand recovery from Q1 macro softness reinforce the segment’s stability.
- Margin Expansion Levers: Higher factory utilization and improved pricing in PD segment drive sequential gross margin gains.
- Growth Investments: Specialty film and inductor lines represent multi-year TAM expansion plays, with near-term revenue from film and longer-term from inductors.
- Capital Allocation Flexibility: Robust cash flow and low leverage support ongoing buybacks and opportunistic M&A without straining the balance sheet.
Risks
Tariff volatility remains a watchpoint, though Knowles’ proximity manufacturing limits material exposure. Margin expansion depends on continued high factory utilization and favorable product mix, which could be challenged by demand shifts or operational hiccups. The pace of specialty film and inductor adoption, as well as the timing and integration of any acquisitions, represent execution risks that could impact the growth trajectory.
Forward Outlook
For Q3 2025, Knowles guided to:
- Revenue of $144 to $154 million
- EPS of $0.29 to $0.33
- Adjusted EBITDA margin of 22% to 24%
- Operating cash flow of $20 to $30 million
For full-year 2025, management maintained expectations for:
- Operating cash flow at 16% to 20% of revenue
- Capital spending at approximately 5% of revenue, reflecting specialty film expansion
Management highlighted:
- Sequential and YoY growth expected in both Q3 and Q4, underpinned by strong backlog and order activity
- Gross margins to remain in the low 50% range for the remainder of the year
Takeaways
Knowles is entering a period of sustained organic growth, fueled by strong bookings, normalized distribution inventory, and strategic investments in capacity and product expansion.
- Order Momentum: Broad-based bookings growth and a robust pipeline in both segments support confidence in sustained revenue acceleration.
- Margin and Cash Generation: Operational leverage from higher utilization and disciplined cost control underpin margin expansion and healthy cash flows.
- Growth Optionality: Specialty film and inductor lines, along with an active M&A pipeline, provide multiple avenues for TAM expansion and long-term value creation.
Conclusion
Knowles delivered a standout Q2, with bookings and execution across core segments supporting a higher organic growth profile. Strategic investments and disciplined capital allocation position the company for continued margin expansion and market share gains into 2026.
Industry Read-Through
Knowles’ results reinforce the resilience of MedTech and defense end markets—essential device demand remains steady even amid macro volatility, and proximity manufacturing offers a blueprint for tariff mitigation. The normalization of channel inventory and return of distribution demand signal that broader industrial and specialty component supply chains are stabilizing. Specialty film and inductor investment themes highlight a sector-wide push toward product innovation and TAM expansion, while disciplined capital allocation and M&A optionality reflect a broader industry trend toward balance sheet strength and strategic flexibility. Investors in the electronic components and MedTech supply chain should watch for similar order momentum, margin drivers, and capital deployment patterns across peers.